ROS proto-oncogene 1 (ROS1 gene) fusions are present in various tumour types, including 1% to 2% of non-small cell lung cancer (NSCLC) [1]. The resulting oncoprotein causes continuous kinase activation and downstream signalling, and leads to tumour growth [2]. This evidence concerns the gene ROS1 and neoplasm.